UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.15 +0.15 (+0.19%) GOLD FUTURES
2,310.60 -0.40 (-0.02%) DOW
38,153.53 +250.24 (+0.66%) Bitcoin GBP
47,114.93 +1,453.00 (+3.18%)
Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:43PM EDT. Market open.
| Previous close | 4.0900 |
| Open | 4.1300 |
| Bid | 4.0500 x 2800 |
| Ask | 4.1200 x 100 |
| Day's range | 3.9250 - 4.2200 |
| 52-week range | 1.6300 - 8.8300 |
| Volume | |
| Avg. volume | 2,638,286 |
| Market cap | 463.666M |
| Beta (5Y monthly) | 1.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
- Zacks
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.